US Stocks Dragon uye Tiger Report: BTK degrader inopinda muuropi nehumbowo hutsva; akadonha 78%, SMDC haina PR
Kufambira mberi kwemashoko matsva: Phase 1 oral brain-permeable BTK degrader NX-5948 inoshandiswa kurapa B-cell malignant lymphoma, uye uchapupu hwekutanga hwekliniki hwebasa reCNS hwakaziviswa; Phase 1 BCR-ABL inhibitor ELVN-001 inoshandiswa kurapa CML (chronic myeloid leukemia), uye Phase 1 PoC data yakaziviswa.
Zvitsva zvipingamupinyi zve data: Phase 1/2 VISTA monoclonal antibody KVA12123 inoshandiswa kurapa mazamu akasimba, uye dhiyabhorosi yekutanga yekiriniki yeData yeChikamu 1/2 inoratidzwa, uye hapana ORR muboka remishonga imwe chete; Phase 1 5T4/4-1BB dual antibody ALG.APV-527 inoshandiswa kurapa mapundu akasimba, uye data inovandudzwa. Paiva nevarwere ve2 SD mwedzi 1 yapfuura, uye ikozvino kune murwere we1 SD chete; Phase 2 yakagadzirira-yakagadzirirwa reprogrammed macrophage ALLOCETRA inoshandiswa kurapa sepsis, uye Phase 2 yepamusoro-mutsara data inobudiswa, uye yekutanga haina kuenzana uye haina nhamba inokosha; Phase 1 Ī±vĪ²3 SMDC mushonga VIP236 inoshandiswa kurapa mamota akasimba, uye data reChikamu 1 rinogadziridzwa, uye hapana PR yakaitika.